HIV/AIDS
FDA Approves New Roche Dual-PCR Target HIV-1 Test
Published in AIDS Weekly, June 14th, 2010
Roche Molecular Diagnostics (SIX: RO, ROG: OTCQX: RHHBY) announced that the Food and Drug Administration (FDA) approved its new dual-PCR target HIV-1 viral load test to quantify the amount of virus in a patient's blood. The COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 is the first quantitative viral load test to amplify and detect two separate regions of a target genome and offers a fully automated and reliable solution for physicians to make informed treatment decisions for HIV-1 patients undergoing antiretroviral therapy.
"With the introduction of this test, Roche is the only company in the world to offer a dual-PCR target quantitative viral load...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2010-06-14)
More Articles from AIDS Weekly
- Public Health
New public health study findings have been reported from University of California - Antiretrovirals
New antiretrovirals findings from D.K. Ekouevi and co-researchers published - HIV/AIDS
Data from University of Michigan advance knowledge in HIV/AIDS - HIV/AIDS
Data on HIV/AIDS detailed by S.Q. Han and co-authors - Biosocial Science
Data on biosocial science described by R. Fakolade et al - Oxidoreductases
Findings from Chinese University of Hong Kong provide new insights into oxidoreductases - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
